 | • レポートコード：D0804-16136 • 出版社/出版日：GlobalInfoResearch / 2020年7月28日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、101ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、麻薬（オピオイド）薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。麻薬（オピオイド）薬の種類別市場規模（コデイン、フェンタニル、ヒドロコドン、ヒドロモルホン、メペリジン、メタドン、その他）、用途別市場規模（鎮痛申請、麻酔申請）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Pfizer、Merck、Mallinckrodt、Teva、Johnson & Johnson、Purdue Pharma、Hikma Pharmaceuticals、Collegium、Amneal Pharma、Mylan、Sun Pharma、Endo Pharmaceuticals、Allergan ・地域別グローバル市場分析 2015年-2020年 ・麻薬（オピオイド）薬の北米市場（アメリカ、カナダ、メキシコ） ・麻薬（オピオイド）薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・麻薬（オピオイド）薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・麻薬（オピオイド）薬の南米市場（ブラジル、アルゼンチン） ・麻薬（オピオイド）薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：コデイン、フェンタニル、ヒドロコドン、ヒドロモルホン、メペリジン、メタドン、その他 ・用途別分析：鎮痛申請、麻酔申請 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Narcotic (Opioid) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Narcotic (Opioid) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Narcotic (Opioid) Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Narcotic (Opioid) Drugs market has been segmented into:
Codeine
Fentanyl
Hydrocodone
Hydromorphone
Meperidine
Methadone
Others
By Application, Narcotic (Opioid) Drugs has been segmented into:
Pain Relief Application
Anesthesia Application
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Narcotic (Opioid) Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Narcotic (Opioid) Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Narcotic (Opioid) Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Narcotic (Opioid) Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Narcotic (Opioid) Drugs Market Share Analysis
Narcotic (Opioid) Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Narcotic (Opioid) Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Narcotic (Opioid) Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Narcotic (Opioid) Drugs are:
Pfizer
Merck
Mallinckrodt
Teva
Johnson & Johnson
Purdue Pharma
Hikma Pharmaceuticals
Collegium
Amneal Pharma
Mylan
Sun Pharma
Endo Pharmaceuticals
Allergan
Table of Contents
1 Narcotic (Opioid) Drugs Market Overview
1.1 Product Overview and Scope of Narcotic (Opioid) Drugs
1.2 Classification of Narcotic (Opioid) Drugs by Type
1.2.1 Global Narcotic (Opioid) Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Narcotic (Opioid) Drugs Revenue Market Share by Type in 2019
1.2.3 Codeine
1.2.4 Fentanyl
1.2.5 Hydrocodone
1.2.6 Hydromorphone
1.2.7 Meperidine
1.2.8 Methadone
1.2.9 Others
1.3 Global Narcotic (Opioid) Drugs Market by Application
1.3.1 Overview: Global Narcotic (Opioid) Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Pain Relief Application
1.3.3 Anesthesia Application
1.4 Global Narcotic (Opioid) Drugs Market by Regions
1.4.1 Global Narcotic (Opioid) Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Narcotic (Opioid) Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Narcotic (Opioid) Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Narcotic (Opioid) Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Narcotic (Opioid) Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Narcotic (Opioid) Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Narcotic (Opioid) Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Merck SWOT Analysis
2.2.4 Merck Product and Services
2.2.5 Merck Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Mallinckrodt
2.3.1 Mallinckrodt Details
2.3.2 Mallinckrodt Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Mallinckrodt SWOT Analysis
2.3.4 Mallinckrodt Product and Services
2.3.5 Mallinckrodt Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Teva
2.4.1 Teva Details
2.4.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Teva SWOT Analysis
2.4.4 Teva Product and Services
2.4.5 Teva Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Johnson & Johnson SWOT Analysis
2.5.4 Johnson & Johnson Product and Services
2.5.5 Johnson & Johnson Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Purdue Pharma
2.6.1 Purdue Pharma Details
2.6.2 Purdue Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Purdue Pharma SWOT Analysis
2.6.4 Purdue Pharma Product and Services
2.6.5 Purdue Pharma Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Hikma Pharmaceuticals
2.7.1 Hikma Pharmaceuticals Details
2.7.2 Hikma Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Hikma Pharmaceuticals SWOT Analysis
2.7.4 Hikma Pharmaceuticals Product and Services
2.7.5 Hikma Pharmaceuticals Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Collegium
2.8.1 Collegium Details
2.8.2 Collegium Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Collegium SWOT Analysis
2.8.4 Collegium Product and Services
2.8.5 Collegium Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Amneal Pharma
2.9.1 Amneal Pharma Details
2.9.2 Amneal Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Amneal Pharma SWOT Analysis
2.9.4 Amneal Pharma Product and Services
2.9.5 Amneal Pharma Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Mylan SWOT Analysis
2.10.4 Mylan Product and Services
2.10.5 Mylan Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sun Pharma
2.11.1 Sun Pharma Details
2.11.2 Sun Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sun Pharma SWOT Analysis
2.11.4 Sun Pharma Product and Services
2.11.5 Sun Pharma Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.12 Endo Pharmaceuticals
2.12.1 Endo Pharmaceuticals Details
2.12.2 Endo Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Endo Pharmaceuticals SWOT Analysis
2.12.4 Endo Pharmaceuticals Product and Services
2.12.5 Endo Pharmaceuticals Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.13 Allergan
2.13.1 Allergan Details
2.13.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Allergan SWOT Analysis
2.13.4 Allergan Product and Services
2.13.5 Allergan Narcotic (Opioid) Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Narcotic (Opioid) Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Narcotic (Opioid) Drugs Players Market Share
3.2.2 Top 10 Narcotic (Opioid) Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Narcotic (Opioid) Drugs Revenue and Market Share by Regions
4.2 North America Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
5 North America Narcotic (Opioid) Drugs Revenue by Countries
5.1 North America Narcotic (Opioid) Drugs Revenue by Countries (2015-2020)
5.2 USA Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
6 Europe Narcotic (Opioid) Drugs Revenue by Countries
6.1 Europe Narcotic (Opioid) Drugs Revenue by Countries (2015-2020)
6.2 Germany Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
6.4 France Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Narcotic (Opioid) Drugs Revenue by Countries
7.1 Asia-Pacific Narcotic (Opioid) Drugs Revenue by Countries (2015-2020)
7.2 China Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
7.5 India Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
8 South America Narcotic (Opioid) Drugs Revenue by Countries
8.1 South America Narcotic (Opioid) Drugs Revenue by Countries (2015-2020)
8.2 Brazil Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Narcotic (Opioid) Drugs by Countries
9.1 Middle East & Africa Narcotic (Opioid) Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Narcotic (Opioid) Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Narcotic (Opioid) Drugs Market Forecast by Type (2019-2024)
10.3 Codeine Revenue Growth Rate (2015-2025)
10.4 Fentanyl Revenue Growth Rate (2015-2025)
10.5 Hydrocodone Revenue Growth Rate (2015-2025)
10.6 Hydromorphone Revenue Growth Rate (2015-2025)
10.7 Meperidine Revenue Growth Rate (2015-2025)
10.8 Methadone Revenue Growth Rate (2015-2025)
10.9 Others Revenue Growth Rate (2015-2025)
11 Global Narcotic (Opioid) Drugs Market Segment by Application
11.1 Global Narcotic (Opioid) Drugs Revenue Market Share by Application (2015-2020)
11.2 Narcotic (Opioid) Drugs Market Forecast by Application (2019-2024)
11.3 Pain Relief Application Revenue Growth (2015-2020)
11.4 Anesthesia Application Revenue Growth (2015-2020)
12 Global Narcotic (Opioid) Drugs Market Size Forecast (2021-2025)
12.1 Global Narcotic (Opioid) Drugs Market Size Forecast (2021-2025)
12.2 Global Narcotic (Opioid) Drugs Market Forecast by Regions (2021-2025)
12.3 North America Narcotic (Opioid) Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Narcotic (Opioid) Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Narcotic (Opioid) Drugs Revenue Market Forecast (2021-2025)
12.6 South America Narcotic (Opioid) Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Narcotic (Opioid) Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Narcotic (Opioid) Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Narcotic (Opioid) Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Narcotic (Opioid) Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Narcotic (Opioid) Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer Narcotic (Opioid) Drugs Major Business
Table 7. Pfizer Narcotic (Opioid) Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer Narcotic (Opioid) Drugs Product and Solutions
Table 10. Pfizer Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Merck Corporate Information, Location and Competitors
Table 12. Merck Narcotic (Opioid) Drugs Major Business
Table 13. Merck Narcotic (Opioid) Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Merck SWOT Analysis
Table 15. Merck Narcotic (Opioid) Drugs Product and Solutions
Table 16. Merck Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Mallinckrodt Corporate Information, Location and Competitors
Table 18. Mallinckrodt Narcotic (Opioid) Drugs Major Business
Table 19. Mallinckrodt Narcotic (Opioid) Drugs Total Revenue (USD Million) (2017-2018)
Table 20. Mallinckrodt SWOT Analysis
Table 21. Mallinckrodt Narcotic (Opioid) Drugs Product and Solutions
Table 22. Mallinckrodt Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Teva Corporate Information, Location and Competitors
Table 24. Teva Narcotic (Opioid) Drugs Major Business
Table 25. Teva Narcotic (Opioid) Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Teva SWOT Analysis
Table 27. Teva Narcotic (Opioid) Drugs Product and Solutions
Table 28. Teva Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Johnson & Johnson Corporate Information, Location and Competitors
Table 30. Johnson & Johnson Narcotic (Opioid) Drugs Major Business
Table 31. Johnson & Johnson Narcotic (Opioid) Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Johnson & Johnson SWOT Analysis
Table 33. Johnson & Johnson Narcotic (Opioid) Drugs Product and Solutions
Table 34. Johnson & Johnson Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Purdue Pharma Corporate Information, Location and Competitors
Table 36. Purdue Pharma Narcotic (Opioid) Drugs Major Business
Table 37. Purdue Pharma Narcotic (Opioid) Drugs Total Revenue (USD Million) (2017-2018)
Table 38. Purdue Pharma SWOT Analysis
Table 39. Purdue Pharma Narcotic (Opioid) Drugs Product and Solutions
Table 40. Purdue Pharma Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Hikma Pharmaceuticals Corporate Information, Location and Competitors
Table 42. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Major Business
Table 43. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Hikma Pharmaceuticals SWOT Analysis
Table 45. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Product and Solutions
Table 46. Hikma Pharmaceuticals Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Collegium Corporate Information, Location and Competitors
Table 48. Collegium Narcotic (Opioid) Drugs Major Business
Table 49. Collegium Narcotic (Opioid) Drugs Total Revenue (USD Million) (2017-2018)
Table 50. Collegium SWOT Analysis
Table 51. Collegium Narcotic (Opioid) Drugs Product and Solutions
Table 52. Collegium Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Amneal Pharma Corporate Information, Location and Competitors
Table 54. Amneal Pharma Narcotic (Opioid) Drugs Major Business
Table 55. Amneal Pharma Narcotic (Opioid) Drugs Total Revenue (USD Million) (2017-2018)
Table 56. Amneal Pharma SWOT Analysis
Table 57. Amneal Pharma Narcotic (Opioid) Drugs Product and Solutions
Table 58. Amneal Pharma Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Mylan Corporate Information, Location and Competitors
Table 60. Mylan Narcotic (Opioid) Drugs Major Business
Table 61. Mylan Narcotic (Opioid) Drugs Total Revenue (USD Million) (2017-2018)
Table 62. Mylan SWOT Analysis
Table 63. Mylan Narcotic (Opioid) Drugs Product and Solutions
Table 64. Mylan Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Sun Pharma Corporate Information, Location and Competitors
Table 66. Sun Pharma Narcotic (Opioid) Drugs Major Business
Table 67. Sun Pharma Narcotic (Opioid) Drugs Total Revenue (USD Million) (2017-2018)
Table 68. Sun Pharma SWOT Analysis
Table 69. Sun Pharma Narcotic (Opioid) Drugs Product and Solutions
Table 70. Sun Pharma Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Endo Pharmaceuticals Corporate Information, Location and Competitors
Table 72. Endo Pharmaceuticals Narcotic (Opioid) Drugs Major Business
Table 73. Endo Pharmaceuticals Narcotic (Opioid) Drugs Total Revenue (USD Million) (2017-2018)
Table 74. Endo Pharmaceuticals SWOT Analysis
Table 75. Endo Pharmaceuticals Narcotic (Opioid) Drugs Product and Solutions
Table 76. Endo Pharmaceuticals Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Allergan Corporate Information, Location and Competitors
Table 78. Allergan Narcotic (Opioid) Drugs Major Business
Table 79. Allergan Narcotic (Opioid) Drugs Total Revenue (USD Million) (2017-2018)
Table 80. Allergan SWOT Analysis
Table 81. Allergan Narcotic (Opioid) Drugs Product and Solutions
Table 82. Allergan Narcotic (Opioid) Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Narcotic (Opioid) Drugs Revenue (Million USD) by Players (2015-2020)
Table 84. Global Narcotic (Opioid) Drugs Revenue Share by Players (2015-2020)
Table 85. Global Narcotic (Opioid) Drugs Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Narcotic (Opioid) Drugs Revenue Market Share by Regions (2015-2020)
Table 87. North America Narcotic (Opioid) Drugs Revenue by Countries (2015-2020)
Table 88. North America Narcotic (Opioid) Drugs Revenue Market Share by Countries (2015-2020)
Table 89. Europe Narcotic (Opioid) Drugs Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Narcotic (Opioid) Drugs Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Narcotic (Opioid) Drugs Revenue by Countries (2015-2020)
Table 92. South America Narcotic (Opioid) Drugs Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Narcotic (Opioid) Drugs Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Narcotic (Opioid) Drugs Revenue Market Share by Countries (2015-2020)
Table 95. Global Narcotic (Opioid) Drugs Revenue (Million USD) by Type (2015-2020)
Table 96. Global Narcotic (Opioid) Drugs Revenue Share by Type (2015-2020)
Table 97. Global Narcotic (Opioid) Drugs Revenue Forecast by Type (2021-2025)
Table 98. Global Narcotic (Opioid) Drugs Revenue by Application (2015-2020)
Table 99. Global Narcotic (Opioid) Drugs Revenue Share by Application (2015-2020)
Table 100. Global Narcotic (Opioid) Drugs Revenue Forecast by Application (2021-2025)
Table 101. Global Narcotic (Opioid) Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Narcotic (Opioid) Drugs Picture
Figure 2. Global Narcotic (Opioid) Drugs Revenue Market Share by Type in 2019
Figure 3. Codeine Picture
Figure 4. Fentanyl Picture
Figure 5. Hydrocodone Picture
Figure 6. Hydromorphone Picture
Figure 7. Meperidine Picture
Figure 8. Methadone Picture
Figure 9. Others Picture
Figure 10. Narcotic (Opioid) Drugs Revenue Market Share by Application in 2019
Figure 11. Pain Relief Application Picture
Figure 12. Anesthesia Application Picture
Figure 13. Global Narcotic (Opioid) Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Narcotic (Opioid) Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Narcotic (Opioid) Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Narcotic (Opioid) Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Narcotic (Opioid) Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Narcotic (Opioid) Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Narcotic (Opioid) Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Narcotic (Opioid) Drugs Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Narcotic (Opioid) Drugs Revenue Market Share in 2019
Figure 22. Global Top 10 Players Narcotic (Opioid) Drugs Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Narcotic (Opioid) Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Narcotic (Opioid) Drugs Revenue Market Share by Regions (2015-2020)
Figure 26. Global Narcotic (Opioid) Drugs Revenue Market Share by Regions in 2018
Figure 27. North America Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 28. Europe Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 30. South America Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 32. North America Narcotic (Opioid) Drugs Revenue Market Share by Countries (2015-2020)
Figure 33. North America Narcotic (Opioid) Drugs Revenue Market Share by Countries in 2019
Figure 34. USA Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 35. Canada Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 37. Europe Narcotic (Opioid) Drugs Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Narcotic (Opioid) Drugs Revenue Market Share by Countries in 2019
Figure 39. Germany Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 40. UK Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 41. France Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Russia Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 43. Italy Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Narcotic (Opioid) Drugs Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Narcotic (Opioid) Drugs Revenue Market Share by Countries in 2019
Figure 46. China Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 47. Japan Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 48. Korea Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 49. India Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 51. South America Narcotic (Opioid) Drugs Revenue Market Share by Countries (2015-2020)
Figure 52. South America Narcotic (Opioid) Drugs Revenue Market Share by Countries in 2019
Figure 53. Brazil Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Narcotic (Opioid) Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Narcotic (Opioid) Drugs Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 58. UAE Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Narcotic (Opioid) Drugs Revenue and Growth Rate (2015-2020)
Figure 61. Global Narcotic (Opioid) Drugs Revenue Share by Type (2015-2020)
Figure 62. Global Narcotic (Opioid) Drugs Revenue Share by Type in 2019
Figure 63. Global Narcotic (Opioid) Drugs Market Share Forecast by Type (2021-2025)
Figure 64. Global Codeine Revenue Growth Rate (2015-2020)
Figure 65. Global Fentanyl Revenue Growth Rate (2015-2020)
Figure 66. Global Hydrocodone Revenue Growth Rate (2015-2020)
Figure 67. Global Hydromorphone Revenue Growth Rate (2015-2020)
Figure 68. Global Meperidine Revenue Growth Rate (2015-2020)
Figure 69. Global Methadone Revenue Growth Rate (2015-2020)
Figure 70. Global Others Revenue Growth Rate (2015-2020)
Figure 71. Global Narcotic (Opioid) Drugs Revenue Share by Application (2015-2020)
Figure 72. Global Narcotic (Opioid) Drugs Revenue Share by Application in 2019
Figure 73. Global Narcotic (Opioid) Drugs Market Share Forecast by Application (2021-2025)
Figure 74. Global Pain Relief Application Revenue Growth Rate (2015-2020)
Figure 75. Global Anesthesia Application Revenue Growth Rate (2015-2020)
Figure 76. Global Narcotic (Opioid) Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Narcotic (Opioid) Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Narcotic (Opioid) Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Narcotic (Opioid) Drugs Revenue Market Forecast (2021-2025)
Figure 80. Europe Narcotic (Opioid) Drugs Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Narcotic (Opioid) Drugs Revenue Market Forecast (2021-2025)
Figure 82. South America Narcotic (Opioid) Drugs Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Narcotic (Opioid) Drugs Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
オピオイド誘発性副作用治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Opioid Induced Side Effects Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…- オピオイド離脱管理の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Opioid Withdrawal Management market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Opioid Withdrawa…
- オピオイド使用障害および薬物中毒治療用医療機器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Medical Devices Used For Opioid Use Disorder and Drug Addiction Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic …
- 経口薄膜薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oral Thin Film Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.0% in the forecast period of 2020 to 2025 and will expected to reach USD 2769.8 million by 2025, from USD 2033 million in 2019. The Oral Thin Film Dr…
- 加齢性黄斑変性症（ARMD）薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Age-relatedMacularDegeneration (ARMD) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, val…